14-77218327-C-G
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_020431.4(TMEM63C):c.-13-474C>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.679 in 151,374 control chromosomes in the GnomAD database, including 35,185 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.68 ( 35185 hom., cov: 29)
Consequence
TMEM63C
NM_020431.4 intron
NM_020431.4 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: 0.0920
Publications
5 publications found
Genes affected
TMEM63C (HGNC:23787): (transmembrane protein 63C) Enables calcium activated cation channel activity. Involved in cation transport. Predicted to be integral component of membrane. Predicted to be active in plasma membrane. Biomarker of focal segmental glomerulosclerosis. [provided by Alliance of Genome Resources, Apr 2022]
TMEM63C Gene-Disease associations (from GenCC):
- spastic paraplegia 87, autosomal recessiveInheritance: AR Classification: MODERATE, LIMITED Submitted by: G2P, Ambry Genetics
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.98).
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.723 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| TMEM63C | NM_020431.4 | c.-13-474C>G | intron_variant | Intron 2 of 23 | ENST00000298351.5 | NP_065164.2 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.679 AC: 102730AN: 151254Hom.: 35179 Cov.: 29 show subpopulations
GnomAD3 genomes
AF:
AC:
102730
AN:
151254
Hom.:
Cov.:
29
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.679 AC: 102781AN: 151374Hom.: 35185 Cov.: 29 AF XY: 0.682 AC XY: 50396AN XY: 73900 show subpopulations
GnomAD4 genome
AF:
AC:
102781
AN:
151374
Hom.:
Cov.:
29
AF XY:
AC XY:
50396
AN XY:
73900
show subpopulations
African (AFR)
AF:
AC:
24303
AN:
41238
American (AMR)
AF:
AC:
11188
AN:
15232
Ashkenazi Jewish (ASJ)
AF:
AC:
2471
AN:
3468
East Asian (EAS)
AF:
AC:
3303
AN:
5108
South Asian (SAS)
AF:
AC:
3453
AN:
4794
European-Finnish (FIN)
AF:
AC:
7696
AN:
10356
Middle Eastern (MID)
AF:
AC:
203
AN:
290
European-Non Finnish (NFE)
AF:
AC:
47971
AN:
67878
Other (OTH)
AF:
AC:
1490
AN:
2100
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.478
Heterozygous variant carriers
0
1464
2928
4393
5857
7321
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
814
1628
2442
3256
4070
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
2348
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.